- Home
- YSG vs BVS Comparison
YSG vs BVS Comparison
Compare YSG & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YSG
- BVS
- Stock Information
- Founded
- YSG 2016
- BVS 2011
- Country
- YSG China
- BVS United States
- Employees
- YSG N/A
- BVS N/A
- Industry
- YSG Package Goods/Cosmetics
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- YSG Consumer Discretionary
- BVS Health Care
- Exchange
- YSG Nasdaq
- BVS Nasdaq
- Market Cap
- YSG 529.3M
- BVS 496.7M
- IPO Year
- YSG 2020
- BVS 2021
- Fundamental
- Price
- YSG $9.48
- BVS $6.46
- Analyst Decision
- YSG
- BVS Strong Buy
- Analyst Count
- YSG 0
- BVS 4
- Target Price
- YSG N/A
- BVS $15.00
- AVG Volume (30 Days)
- YSG 599.8K
- BVS 325.5K
- Earning Date
- YSG 08-19-2025
- BVS 08-05-2025
- Dividend Yield
- YSG N/A
- BVS N/A
- EPS Growth
- YSG N/A
- BVS N/A
- EPS
- YSG N/A
- BVS N/A
- Revenue
- YSG $475,930,821.00
- BVS $567,699,000.00
- Revenue This Year
- YSG $17.93
- BVS N/A
- Revenue Next Year
- YSG $12.79
- BVS $6.11
- P/E Ratio
- YSG N/A
- BVS N/A
- Revenue Growth
- YSG 0.90
- BVS 8.60
- 52 Week Low
- YSG $2.60
- BVS $5.28
- 52 Week High
- YSG $9.81
- BVS $14.38
- Technical
- Relative Strength Index (RSI)
- YSG 80.20
- BVS 43.37
- Support Level
- YSG $8.55
- BVS $6.32
- Resistance Level
- YSG $9.81
- BVS $7.08
- Average True Range (ATR)
- YSG 0.81
- BVS 0.23
- MACD
- YSG 0.22
- BVS 0.02
- Stochastic Oscillator
- YSG 92.55
- BVS 25.00
About YSG Yatsen Holding Limited
Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.